Customizing Care in CLL With BTK Inhibitors

Chair, John C. Byrd, MD, Jacqueline Barrientos, MD, MS, and Kerry A. Rogers, MD, discuss chronic lymphocytic leukemia in this CME/MOC activity titled “Customizing Care in CLL With BTK Inhibitors: Evidence and Applications for Therapy Selection, Sequencing, and Safety Management.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/HZU865. CME/MOC credit will be available until January 9, 2023.

свернуть